Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jesus Rangel-Santiago"'
Autor:
Gabriela Antonio-Andres, Marco A Durán-Padilla, Belen Tirado-Rodriguez, Mario I. Vega, Jorge Barrios-Payán, Guillermina J. Baay-Guzman, Jesus Rangel-Santiago, Dulce Mata-Espinosa, Sara Huerta-Yepez, Miguel Klünder-Klünder, Rogelio Hernández-Pando
Publikováno v:
Future Microbiology. 13:785-798
Aim: Investigate the role of hypoxia-inducible factor-1α (HIF-1α) in pulmonary tuberculosis (TB). Methods & results: A model of progressive pulmonary TB in BALB/c mice, immunohistochemistry and digital pathology were used. High HIF-1α expression w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7714fd999d5cdc581f4f35f6fe3ed89d
https://doi.org/10.2217/fmb-2017-0168
https://doi.org/10.2217/fmb-2017-0168
Autor:
Jesus Rangel-Santiago, Jose Torres Nava, Elva Jiménez-Hernández, Gabriela Antonio-Andres, Gustavo Ulises Martinez-Ruiz, Sara Huerta-Yepez, Aurora Medina-Sanson, Briceida López-Martínez, Mario I. Vega, Miguel Klünder-Klünder, Belen Tirado-Rodriguez
Publikováno v:
Leukemia & Lymphoma. 59:2628-2638
Resistance to chemotherapy hinders the successful treatment of acute lymphoblastic leukemia (ALL). The multi-drug resistance-1 (MDR1/ABCB1) gene encodes P-glycoprotein (P-gp), which plays an important role in chemoresistance; however, its transcripti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6a4ad0ed5d694d339b7c6e69884c11d
https://doi.org/10.1080/10428194.2018.1448083
https://doi.org/10.1080/10428194.2018.1448083
Autor:
Gabriela, Antonio-Andrés, Jesus, Rangel-Santiago, Belen, Tirado-Rodríguez, Gustavo U, Martinez-Ruiz, Miguel, Klunder-Klunder, Mario I, Vega, Briceida, Lopez-Martinez, Elva, Jiménez-Hernández, Jose, Torres Nava, Aurora, Medina-Sanson, Sara, Huerta-Yepez
Publikováno v:
Leukemialymphoma. 59(11)
Resistance to chemotherapy hinders the successful treatment of acute lymphoblastic leukemia (ALL). The multi-drug resistance-1 (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::67b7af6f01292172b71dcb26900096a7
https://pubmed.ncbi.nlm.nih.gov/29616858
https://pubmed.ncbi.nlm.nih.gov/29616858
Autor:
Karla A. Lopez-Bochm, Rogelio Hernández-Pando, Marco A Durán-Padilla, Guillermina J. Baay-Guzman, Jesus Rangel-Santiago, Beatriz L. Garcia-Romero, Mario I. Vega, Daniel Hernández-Cueto, Sara Huerta-Yepez, Gerardo Pantoja-Escobar
Publikováno v:
Tuberculosis (Edinburgh, Scotland). 96
Mycobacterium tuberculosis (M. tb) is the etiological agent of pulmonary tuberculosis (TB); this disease remains a worldwide health problem. Yin-Yang-1 (YY1) plays a major role in the maintenance and progression of some pulmonary diseases, including
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f7f7242e73d70bf9c8f278a20f36b7a
https://pubmed.ncbi.nlm.nih.gov/26786659
https://pubmed.ncbi.nlm.nih.gov/26786659
Autor:
Aurora Medina-Sanson, Gabriela andres-Antonio, Elba Jimenez, Rosana Pelayo, Ana B. Tirado-Rodriguez, Jesus Rangel-Santiago, Mario I. Vega, Briseida Lopez, Guillermo Aquino-Jarquin, Elisa Dorantes-Acosta, Benjamin Bonavida, Sara Huerta-Yepez
Publikováno v:
Cancer Research. 72:4330-4330
Leukemia is the most common cancer among children under the age of 15 years in the United States and many developed countries. In recent years, there has been the emergence of novel therapeutic drugs for this disease. However, the development of drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ffbb218f0d10afa9ebd5408d7f58e27
https://doi.org/10.1158/1538-7445.am2012-4330
https://doi.org/10.1158/1538-7445.am2012-4330
Autor:
Gabriela andres-Antonio, Guillermo Aquino-Jarquin, Elisa Dorantes-Acosta, Ana B. Tirado-Rodriguez, Aurora Medina-Sanson, Jesus Rangel-Santiago, Mario I. Vega, Sara Huerta-Yepez, Rosana Pelayo, Briseida Lopez, Elba Jimenez, Benjamin Bonavida
Publikováno v:
Blood. 118:3567-3567
Abstract 3567 Leukemia is the most common cancer among children under the age of 15 years in the United States and many developed countries. In recent years, there has been the emergence of novel therapeutic drugs for this disease. However, the devel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d73183922d8c5f1ed86d10f53c2f1f8
https://doi.org/10.1182/blood.v118.21.3567.3567
https://doi.org/10.1182/blood.v118.21.3567.3567
Autor:
Antonio-Andrés, Gabriela1, Rangel-Santiago, Jesus1, Tirado-Rodríguez, Belen1, Martinez-Ruiz, Gustavo U.1,2, Klunder-Klunder, Miguel3, Vega, Mario I.4,5, Lopez-Martinez, Briceida6, Jiménez-Hernández, Elva7, Torres Nava, Jose7, Medina-Sanson, Aurora8, Huerta-Yepez, Sara1 shuertay@gmail.com
Publikováno v:
Leukemia & Lymphoma. Nov2018, Vol. 59 Issue 11, p2628-2638. 11p.